|
|
|
Volumn 110, Issue 2, 1998, Pages 98-112
|
|
Hepatitis B and C viruses: Molecular identification and targeted antiviral therapies
|
|
Author keywords
Interferon; Nucleoside analogs; Viral hepatitis
|
|
Indexed keywords
ACICLOVIR;
ADEFOVIR;
ADENINE NUCLEOTIDE DERIVATIVE;
ANTIVIRUS AGENT;
FAMCICLOVIR;
GAMMA INTERFERON;
GANCICLOVIR;
HEPATITIS B VACCINE;
IMMUNOMODULATING AGENT;
INTERLEUKIN 2;
LAMIVUDINE;
LEVAMISOLE;
LOBUCAVIR;
PENCICLOVIR;
PLACEBO;
THYMOSIN;
ANTIVIRAL ACTIVITY;
CHRONIC LIVER DISEASE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG INDUCED DISEASE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOTHERAPY;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MULTICENTER STUDY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
VACCINATION;
VIRUS GENOME;
VIRUS HEPATITIS;
VIRUS INHIBITION;
VIRUS MORPHOLOGY;
VIRUS REPLICATION;
ANIMALS;
ANTIVIRAL AGENTS;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HUMANS;
|
|
EID: 0031918142
PISSN: 1081650X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (77)
|
